Long-term treatment of patient with metastatic melanoma of the trunk

被引：0
|
作者：
Kempa-Kaminska, Natasza [1 ]
机构：
[1] Dolnoslaskie Ctr Onkol Wroclawiu, Oddzial Onkol Klin, Pl Hirszfelda 12, PL-53413 Wroclaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2018年 / 14卷
关键词：
immunotherapy; melanoma; vemurafenib; hepatotoxicity;
D O I：
10.5603/OCP.2018.0063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Currently there has been a huge development in melanoma therapy. There are drugs with high efficacy, but also with a completely new toxicity profile. Below is a case report of a patient treated for metastatic melanoma of the body. Treatment included vemurafenib and immunotherapy in the form of pembrolizumab, a monoclonal antibody blocking PD-1 receptor. Among toxicity, dermatological effects of vemurafenib treatment and hepatotoxicity during immunotherapy were observed mainly in case of treatment with vemurafenib. The applied treatment allowed for several years of survival of the patient in good general condition.
引用
收藏
页码：A19 / A22
页数：4
相关论文
共 50 条
  • [21] Advances in the treatment of metastatic melanoma
    Matikas, A.
    Mavroudis, D.
    ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (01): : 28 - 35
  • [22] Systemic therapy for unresectable metastatic melanoma: Impact of biochemotherapy on long-term survival
    Bedikian, Agop Y.
    Johnson, Marcella M.
    Warneke, Carla L.
    McIntyre, Susan
    Papadopoulos, Nicholas
    Hwu, Wen-Jen
    Kim, Kevin
    Hwu, Patrick
    JOURNAL OF IMMUNOTOXICOLOGY, 2008, 5 (02) : 201 - 207
  • [23] Long-term survival after complete resection of melanoma metastatic to the adrenal gland
    Haigh, PI
    Essner, R
    Wardlaw, JC
    Stern, SL
    Morton, DL
    ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (07) : 633 - 639
  • [24] Long-Term Remissions in Metastatic Malignant Melanoma Following Chemotherapy and Tamoxifen Maintenance
    Metzner, Bernd
    Casper, Jochen
    Hartung, Gernot
    Rosien, Bernd
    Hoelzle, Erhard
    Pelzer, Peter
    Koehne, Claus-Henning
    ONKOLOGIE, 2011, 34 (04): : 208 - 209
  • [25] Autoimmune hemolytic anemia during long-term administration of nivolumab for metastatic melanoma
    Nakajima, Koji
    Korekawa, Ayumi
    Rokunohe, Daiki
    Nakano, Hajime
    Sawamura, Daisuke
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (05) : 141 - 142
  • [26] Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma
    Bedikian, Agop Y.
    Johnson, Marcella M.
    Warneke, Carla L.
    Papadopoulos, Nicholas E.
    Kim, Kevin
    Hwu, Wen-Jen
    Mclntyre, Susan
    Hwu, Patrick
    CANCER INVESTIGATION, 2008, 26 (06) : 624 - 633
  • [27] Long-Term Survival After Complete Resection of Melanoma Metastatic to the Adrenal Gland
    Philip I. Haigh
    Richard Essner
    James C. Wardlaw
    Stacey L. Stern
    Donald L. Morton
    Annals of Surgical Oncology, 1999, 6 : 633 - 639
  • [28] Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities
    Burnett, Mark E.
    Brodland, David G.
    Zitelli, John A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (03) : 661 - 668
  • [29] Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070)
    Baur, Martina
    Gneist, Margit
    Owa, Takashi
    Dittrich, Christian
    MELANOMA RESEARCH, 2007, 17 (05) : 329 - 331
  • [30] Long Term Survival in Metastatic Uveal Melanoma
    Buzzacco, D. M.
    Cebulla, C.
    Olencki, T.
    Abdel-Rahman, M. H.
    Davidoff, F. H.
    Kendra, K.
    Craven, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345